American Axle Recommended Ahead of Earnings Report and 4 Stock Analyses to Follow

Biogen Idec Inc. (NASDAQ:BIIB): Current Price: $161.42

Biogen acquired Elan’s (NYSE:ELN) stake in Tysabri, causing RBC Capital to believe that the deal makes sense from a strategic financial perspective, due to the fact that it will raise Biogen’s margins and lower its tax rate. The firm is convinced that Biogen’s SG&A as a percentage of revenue will decline following the deal and it reiterates its Outperform rating on the stock.

Your 1 Feature Stock Pick for February is hot off the press. Click here to discover it now!

Capture

DigitalGlobe, Inc. (NYSE:DGI): Current Price: $28.50

According to Jefferies, DigitalGlobe’s recently closed merger with GeoEye has shown a great deal of improvement for its long-term prospects. The firm reiterates a Buy rating and increased its price target to $36 from $32 on the stock.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

Capture

Melco Crown Entertainment Ltd. (NASDAQ:MPEL): Current Price: $19.50

Melco Crown’s stock dropped due to fears of a government crackdown on trips to Macau, causing RBC Capital to not expect that the government’s policies will effect VIP visits to the region. Furthermore, the firm is views the company’s Q4 results as solid and it keeps its Outperform rating on the stock.

Your 1 Feature Stock Pick for February is hot off the press. Click here to discover it now!

Capture

American Axle & Manufacturing Holdings Inc. (NYSE:AXL): Current Price: $11.98

Buckingham recommends the company’s shares ahead of tomorrow earnings report. The firm predicts that American Axle will see benefits from limited European exposure and the launch of the K2XX platform and Dodge Ram redesign. The firm gives a Buy rating and a $17 price target on the stock.

Capture

Stryker Corp. (NYSE:SYK): Current Price: $62.60

Baird views the risk/reward for Stryker and Zimmer Holdings (NYSE:ZMH) as continuing to be favorable due to improving EBIT margins, earnings quality, end markets, and undemanding valuations. Both companies have an Outperform rating with Stryker’s price target at $68 and Zimmer’s at $79.

Capture

Don’t Miss: Is Arch Coal a Steal Here?